pubmed-article:11079549 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11079549 | lifeskim:mentions | umls-concept:C0002395 | lld:lifeskim |
pubmed-article:11079549 | lifeskim:mentions | umls-concept:C0521117 | lld:lifeskim |
pubmed-article:11079549 | lifeskim:mentions | umls-concept:C0205217 | lld:lifeskim |
pubmed-article:11079549 | lifeskim:mentions | umls-concept:C0023775 | lld:lifeskim |
pubmed-article:11079549 | lifeskim:mentions | umls-concept:C0918012 | lld:lifeskim |
pubmed-article:11079549 | lifeskim:mentions | umls-concept:C1707520 | lld:lifeskim |
pubmed-article:11079549 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:11079549 | pubmed:dateCreated | 2000-11-15 | lld:pubmed |
pubmed-article:11079549 | pubmed:abstractText | The isoprostane 8,12-iso-iPF2alpha-VI is a sensitive and specific marker of in vivo lipid peroxidation. We found elevated levels in the urine, blood, and cerebrospinal fluid of patients with Alzheimer's disease (AD) that correlated with measures of cognitive and functional impairment, established biomarkers of AD pathology (cerebrospinal fluid tau and amyloid) and the number of apolipoprotein E epsilon4 alleles. These results suggest that 8,12-iso-iPF2alpha-VI is a useful biomarker of oxidative damage in AD. | lld:pubmed |
pubmed-article:11079549 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11079549 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11079549 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11079549 | pubmed:language | eng | lld:pubmed |
pubmed-article:11079549 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11079549 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11079549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11079549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11079549 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11079549 | pubmed:month | Nov | lld:pubmed |
pubmed-article:11079549 | pubmed:issn | 0364-5134 | lld:pubmed |
pubmed-article:11079549 | pubmed:author | pubmed-author:TrojanowskiJ... | lld:pubmed |
pubmed-article:11079549 | pubmed:author | pubmed-author:FitzGeraldG... | lld:pubmed |
pubmed-article:11079549 | pubmed:author | pubmed-author:ClarkC MCM | lld:pubmed |
pubmed-article:11079549 | pubmed:author | pubmed-author:RokachJJ | lld:pubmed |
pubmed-article:11079549 | pubmed:author | pubmed-author:LeeV MVM | lld:pubmed |
pubmed-article:11079549 | pubmed:author | pubmed-author:PraticòDD | lld:pubmed |
pubmed-article:11079549 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11079549 | pubmed:volume | 48 | lld:pubmed |
pubmed-article:11079549 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11079549 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11079549 | pubmed:pagination | 809-12 | lld:pubmed |
pubmed-article:11079549 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:11079549 | pubmed:meshHeading | pubmed-meshheading:11079549... | lld:pubmed |
pubmed-article:11079549 | pubmed:meshHeading | pubmed-meshheading:11079549... | lld:pubmed |
pubmed-article:11079549 | pubmed:meshHeading | pubmed-meshheading:11079549... | lld:pubmed |
pubmed-article:11079549 | pubmed:meshHeading | pubmed-meshheading:11079549... | lld:pubmed |
pubmed-article:11079549 | pubmed:meshHeading | pubmed-meshheading:11079549... | lld:pubmed |
pubmed-article:11079549 | pubmed:meshHeading | pubmed-meshheading:11079549... | lld:pubmed |
pubmed-article:11079549 | pubmed:meshHeading | pubmed-meshheading:11079549... | lld:pubmed |
pubmed-article:11079549 | pubmed:meshHeading | pubmed-meshheading:11079549... | lld:pubmed |
pubmed-article:11079549 | pubmed:meshHeading | pubmed-meshheading:11079549... | lld:pubmed |
pubmed-article:11079549 | pubmed:year | 2000 | lld:pubmed |
pubmed-article:11079549 | pubmed:articleTitle | Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity. | lld:pubmed |
pubmed-article:11079549 | pubmed:affiliation | Center for Experimental Therapeutics, University of Pennsylvania, Philadelphia 19104, USA. | lld:pubmed |
pubmed-article:11079549 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11079549 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:11079549 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11079549 | lld:pubmed |